TOP2A is directly associated with tumor cell proliferation and invasiveness in breast cancer, and expression has been reported to be amplified in TNBC patients with high-risk factors such as large tumor size, high-grade tumor, and lymph node infiltration14,29,30. Here, TOP2A is linked to breast carcinoma.